切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 最新上傳

最新上傳
(
  • 熱門
)

最新上傳

(
  • 熱門
)
MP03-09: Second primary malignancy risk in patients with upper urinary tract urothelial carcinoma in Taiwan - a nationwide population-based study
2022-06-07
MP03-08: Blockade of the autophagic flux suppresses antitumor immunity via programmed death ligand-1 up-regulation in bladder cancer
2022-06-07
MP03-07: The role of lymph node dissection in patients with upper tract urothelial carcinoma without clinical lymph node metastasis undergoing radical nephroureterectomy
2022-06-07
MP03-06: Effects of variant histology on the oncology outcomes of patients with upper tract urothelial carcinoma after radical nephroureterectomy
2022-06-07
MP03-05: Aquaporins are involved in tumor formation and may potentially act as a therapeutic target in urothelial carcinoma
2022-06-07
MP03-04: Cost-effectiveness analysis of immune checkpoint inhibitors in metastatic urothelial cancer, a single-center retrospective study
2022-06-07
MP03-03: New treatment strategies for overcoming the chemoresistance of urothelial carcinoma
2022-06-07
MP03-02: The pan-immune-inflammation value is a new prognostic biomarker in upper tract urothelial carcinoma
2022-06-07
MP03-01: Treatment strategy for dialysis patient with urothelial carcinoma
2022-06-07
MP02-10: Overall survival and techenque survival in elderly peritoneal dialysis patients
2022-06-07
MP02-09: A better method to estimate ureter length in patient who needs DBJ stenting by a formula
2022-06-07
MP02-08: An innovative combination of penile corporeal girth enhancement and erection restoration
2022-06-07
MP02-07: Investigating the clinical utility of three sperm chromatin dispersion (SCD) assays for sperm DNA fragmentation in male infertility
2022-06-07
MP02-06: The more veins ligated intraoperatively; the more pain improved postoperatively after microsurgical varicocelectomy
2022-06-07
MP02-05: The peak systolic velocity of the penile artery might indicate the risk of cardiovascular disease in patients with erectile dysfunction
2022-06-07
MP02-04: The application of hybrid or in the surgery for multiple-times recurrence of adrenal cortical carcinoma
2022-06-07
MP02-03: Ureteral reconstruction for patient with ureteral stricture in more challenging situations
2022-06-07
MP02-02: Laparoendoscopic single-site inguinal herniorrhaphy: Single-institute experience and the outcome comparison of obesity
2022-06-07
MP02-01: Robotic-assisted radical nephroureterectomy with bladder cuff excision using Da Vinci Xi Vs. Si System: Are there any differences?
2022-06-07
MP01-10: Mirabegron is more tolerable than solifenacin in sjogren’s syndrome patients with overactive bladder symptoms
2022-06-07
MP01-09: Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system disorders- a cohort study
2022-06-07
MP01-08: Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics
2022-06-07
MP01-07: Therapeutic outcome of active management in male patients with detrusor underactivity based on clinical diagnosis and videourodynamic classification
2022-06-07
MP01-06: Type D personality is a predictor of worse quality of life in women with non-neurogenic voiding dysfunction
2022-06-07
  • <
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • >
/ 127
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw